Prior to joining the firm, Austin served as an associate at a Chicago law firm where he focused his practice in Hatch-Waxman Act pharmaceutical litigation. His work includes experience with dry powder inhalers, SGLT-2 inhibitors, omega-3 EPA and DHA derivatives, topical patches, and ion-exchange resins.